Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway

Experimental and Molecular Medicine

Volumn 49, Issue 1, 2017, Pages

  Kim, You Sun ^a,b   Kim, Ji Young ^a   Cho, RyeonJin ^b   Shin, Dong Myung ^b   Lee, Sei Won ^b,c   Oh, Yeon Mok ^b,c  

^a Asan Institute for Life Sciences   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; FIBROBLAST GROWTH FACTOR 2; HEPARIN; MESSENGER RNA; POLYCARBONATE; PROTEOHEPARAN SULFATE; SCATTER FACTOR; VASCULOTROPIN; BIOLOGICAL MARKER;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL NANOVESICLE; CELL PROLIFERATION; CELL REGENERATION; CELL SHAPE; CELL STIMULATION; CELL THERAPY; CONTROLLED STUDY; CYTOPLASM VESICLE; ELASTASE-INDUCED EMPHYSEMA; EXOSOME; LUNG ALVEOLUS EPITHELIUM CELL; LUNG EMPHYSEMA; LUNG EPITHELIUM; MOUSE; NONHUMAN; PARTICLE SIZE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE LEVEL; ADIPOSE TISSUE; ANIMAL; CELL LINE; CYTOLOGY; EMPHYSEMA; ENDOCYTOSIS; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; PHENOTYPE; STEM CELL;

ADIPOSE TISSUE; ANIMALS; BIOMARKERS; CELL LINE; CELL-DERIVED MICROPARTICLES; EMPHYSEMA; ENDOCYTOSIS; EXOSOMES; FIBROBLAST GROWTH FACTOR 2; MICE; PHENOTYPE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 85009739505     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2016.127     Document Type: Article

References (49)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620.
2. Schweitzer KS, Johnstone BH, Garrison J, Rush NI, Cooper S, Traktuev DO et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. AmJ Respir Crit Care Med 2011; 183: 215-225.
3. Huh JW, Kim SY, Lee JH, Lee JS, Van Ta Q, Kim M et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol 2011; 301: L255-L266.
4. Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011; 19: 196-203.
5. Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 2006; 173: 171-179.
6. Kim YS, Kim JY, Shin DM, Huh JW, Lee SW, Oh YM. Tracking intravenous adipose-derived mesenchymal stem cells in a model of elastase-induced emphysema. Tuberc Respir Dis (Seoul) 2014; 77: 116-123.
7. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009; 175: 303-313.
8. Aguilar S, Scotton CJ, McNulty K, Nye E, Stamp G, Laurent G et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS ONE 2009; 4: e8013.
9. Lee SH, Jang AS, Kim YE, Cha JY, Kim TH, Jung S et al. Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir Res 2010; 11: 16.
10. Zhen G, Liu H, Gu N, Zhang H, Xu Y, Zhang Z. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci 2008; 13: 3415-3422.
11. Zhen G, Xue Z, Zhao J, Gu N, Tang Z, Xu Y et al. Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy 2010; 12: 605-614.
12. Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010; 299: L760-L770.
13. Cho KS, Roh HJ. Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases. Curr Stem Cell Res Ther 2010; 5: 111-115.
14. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 2010; 107: 5652-5657.
15. Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, LeClair L, Poynter ME et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 2011; 29: 1137-1148.
16. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495.
17. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-2688.
18. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009; 20: 1053-1067.
19. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 2011; 26: 1474-1483.
20. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS ONE 2012; 7: e33115.
21. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110: 2440-2448.
22. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; Chapter 3: Unit 3.22.
23. Jeong D, Jo W, Yoon J, Kim J, Gianchandani S, Gho YS et al. Nanovesicles engineered from ES cells for enhanced cell proliferation. Biomaterials 2014; 35: 9302-9310.
24. Jang SC, Kim OY, Yoon CM, Choi DS, Roh TY, Park J et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 2013; 7: 7698-7710.
25. Stripp BR, Reynolds SD. Maintenance and repair of the bronchiolar epithelium. Proc Am Thorac Soc 2008; 5: 328-333.
26. Aso Y, Yoneda K, Kikkawa Y. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest 1976; 35: 558-568.
27. Adamson IY. Pulmonary toxicity of bleomycin. Environ Health Perspect 1976; 16: 119-126.
28. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA 2011; 108: E1475-E1483.
29. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684-694.
30. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J 2005; 25: 250-258.
31. Yokohori N, Aoshiba K, Nagai A, Respiratory Failure Research Group in Japan. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125: 626-632.
32. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-835.
33. Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 2013; 123: 3025-3036.
34. Yoshida H, Kitaichi T, Urata M, Kurobe H, Kanbara T, Motoki T et al. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation. Ann Thorac Surg 2009; 88: 418-424.
35. Kim HS, Choi DY, Yun SJ, Choi SM, Kang JW, Jung JW et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 2012; 11: 839-849.
36. Tzouvelekis A, Ntolios P, Bouros D. Stem cell treatment for chronic lung diseases. Respiration 2013; 85: 179-192.
37. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010; 38: 215-224.
38. Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S, Gotti E et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 2013; 22: 772-780.
39. Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 2014; 32: 116-125.
40. Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1989; 1: 207-235.
41. Martin GR. The roles of FGFs in the early development of vertebrate limbs. Genes Dev 1998; 12: 1571-1586.
42. Lee BJ, Moon HG, Shin TS, Jeon SG, Lee EY, Gho YS et al. Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-gamma. Exp Mol Med 2011; 43: 169-178.
43. Guzy RD, Stoilov I, Elton TJ, Mecham RP, Ornitz DM. Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin. Am J Respir Cell Mol Biol 2015; 52: 116-128.
44. Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH et al. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem 2014; 289: 22258-22267.
45. Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004; 104: 3257-3266.
46. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic 2010; 11: 675-687.
47. Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN. Characterization of uptake and internalization of exosomes by bladder cancer cells. Biomed Res Int 2014; 2014: 619829.
48. Chua CC, Rahimi N, Forsten-Williams K, Nugent MA. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res 2004; 94: 316-323.
49. Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002; 71: 435-471.